Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

IRWD

Ironwood Pharmaceuticals Inc

Dec 08 • 04:00PM ET

10.48

Dollar change +0.08
Percentage change 0.77	%

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-6.24	Insider Own	2.33%	Shs Outstand	154.03M	Perf Week	1.75%
Market Cap	1.64B	Forward P/E	13.61	EPS next Y	0.77	Insider Trans	0.66%	Shs Float	152.49M	Perf Month	13.54%
Income	-952.28M	PEG	-	EPS next Q	0.20	Inst Own	105.66%	Short Float / Ratio	11.25% / 6.94	Perf Quarter	26.88%
Sales	432.38M	P/S	3.78	EPS this Y	-707.81%	Inst Trans	-3.38%	Short Interest	17.15M	Perf Half Y	-8.23%
Book/sh	-2.07	P/B	-	EPS next Y	113.20%	ROA	-121.74%	Target Price	17.40	Perf Year	-12.01%
Cash/sh	0.71	P/C	14.75	EPS next 5Y	-	ROE	-711.07%	52W Range	8.07 - 12.66	Perf YTD	-15.42%
Dividend	-	P/FCF	7.22	EPS past 5Y	-	ROI	-442.93%	52W High	-17.22%	Beta	0.73
Dividend %	-	Quick Ratio	0.90	Sales past 5Y	7.24%	Gross Margin	99.68%	52W Low	29.78%	ATR	0.36
Employees	219	Current Ratio	0.90	Sales Q/Q	4.70%	Oper. Margin	44.75%	RSI (14)	64.55	Volatility	3.05% 4.16%
Optionable	Yes	Debt/Eq	-	EPS Q/Q	-70.59%	Profit Margin	-220.24%	Rel Volume	0.70	Prev Close	10.40
Shortable	Yes	LT Debt/Eq	-	Earnings	Nov 09 BMO	Payout	0.00%	Avg Volume	2.47M	Price	10.48
Recom	1.60	SMA20	6.80%	SMA50	9.93%	SMA200	3.10%	Volume	1,736,452	Change	0.77%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-09-23	Initiated	Jefferies	Buy	$21
Sep-28-23	Initiated	JMP Securities	Mkt Outperform	$22
Sep-02-22	Initiated	CapitalOne	Overweight	$15
Apr-22-22	Initiated	Piper Sandler	Overweight	$16
Sep-30-20	Downgrade	Wells Fargo	Overweight → Equal Weight	$14 → $9
Jun-17-20	Initiated	Northland Capital	Outperform	$14
Jul-10-19	Resumed	Credit Suisse	Neutral
Mar-27-19	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Feb-25-19	Upgrade	H.C. Wainwright	Sell → Neutral	$14
Jan-24-19	Upgrade	JP Morgan	Underweight → Neutral
Nov-07-18	Downgrade	JP Morgan	Neutral → Underweight
Nov-07-18	Downgrade	Credit Suisse	Outperform → Neutral
Jul-23-18	Initiated	H.C. Wainwright	Sell	$12.50
May-09-18	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Jan-05-18	Downgrade	BofA/Merrill	Buy → Underperform
Dec-06-17	Downgrade	Mizuho	Buy → Neutral	$16
Jul-21-17	Downgrade	JP Morgan	Overweight → Neutral
May-03-17	Initiated	Wells Fargo	Outperform
Apr-07-17	Reiterated	Mizuho	Buy	$21 → $22
Feb-22-17	Reiterated	Barclays	Equal Weight	$13 → $16

Show Previous Ratings

Nov-30-23 09:45AM	Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management (Newsfile)
Nov-21-23 04:01PM	Ironwood Pharmaceuticals to Participate in the Piper Sandler 35th Annual Healthcare Conference (Business Wire)
Nov-10-23 02:45PM	Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2023 Earnings Call Transcript (Insider Monkey)
11:09AM	Ironwood's (IRWD) Q3 Earnings Miss Mark, Linzess Volume Rises (Zacks)
Nov-09-23 10:25PM	Q3 2023 Ironwood Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
08:39AM	Loading…
08:39AM	Ironwood Pharmaceuticals Inc (IRWD) Reports Growth in LINZESS Sales and Maintains Full Year Guidance (GuruFocus.com)
07:46AM	Top 11 Extreme Value Stocks To Buy (Insider Monkey)
07:22AM	Ironwood: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Ironwood Pharmaceuticals Reports Third Quarter 2023 Results (Business Wire)
Oct-26-23 04:01PM	Ironwood Pharmaceuticals to Host Third Quarter 2023 Investor Update Call (Business Wire)
Oct-23-23 07:30AM	Ironwood Releases New IBS-C and CIC Data at the American College of Gastroenterology 2023 Annual Scientific Meeting (Business Wire)
Oct-17-23 12:02PM	Decoding Ownership and Performance: Ironwood Pharmaceuticals Inc(IRWD) (GuruFocus.com)
Oct-16-23 06:00AM	Ironwood Pharmaceuticals Presents Positive Final Data from STARS Nutrition, a Phase II Study of Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) and Colon in Continuity (CIC) at United European Gastroenterology Week (Business Wire)
Oct-05-23 07:30AM	Ironwood to Present New Data at NASPGHAN Annual Meeting Reinforcing Impact of Linaclotide on Functional Constipation in Children and Adolescents Ages 6-17 Years-Old (Business Wire)
Oct-03-23 11:43AM	Ironwood Pharmaceuticals (IRWD): A Hidden Gem or a Potential Risk? An In-Depth Look at Its Valuation (GuruFocus.com)
07:15AM	Loading…
Oct-01-23 07:15AM	Here's How to Lock in a Trade on a Promising Biopharma Name (TheStreet.com)
Sep-26-23 11:48AM	Unveiling Ironwood Pharmaceuticals (IRWD)'s Value: Is It Really Priced Right? A Comprehensive Guide (GuruFocus.com)
Sep-20-23 07:36AM	Ironwood (IRWD) Surges 7.6%: Is This an Indication of Further Gains? (Zacks)
Sep-19-23 12:08PM	Ironwood Pharmaceuticals Inc (IRWD): A Deep Dive into Its Performance Potential (GuruFocus.com) +7.55%
11:39AM	Ironwood Pharmaceuticals (IRWD): A Comprehensive Analysis of Its Market Value (GuruFocus.com)
Sep-12-23 08:32AM	Implied Volatility Surging for Ironwood (IRWD) Stock Options (Zacks)
Sep-07-23 11:30AM	Why Is Ironwood (IRWD) Down 9.6% Since Last Earnings Report? (Zacks)
Aug-12-23 08:50AM	Is There An Opportunity With Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) 49% Undervaluation? (Simply Wall St.)
Aug-09-23 09:24AM	Ironwood's (IRWD) Reports Q2 Loss, Linzess Volume Rises (Zacks) -6.79%
Aug-08-23 11:12PM	Q2 2023 Ironwood Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) -9.16%
11:05AM	Ironwood Pharmaceuticals (IRWD) Q2 Earnings and Revenues Surpass Estimates (Zacks)
09:56AM	Ironwood: Q2 Earnings Snapshot (AP Finance)
07:00AM	Ironwood Pharmaceuticals Reports Second Quarter 2023 Results; Raises Full Year 2023 LINZESS® U.S. Net Sales and Ironwood Revenue Guidance (Business Wire)
Jul-28-23 02:56PM	10 Best Small Cap Pharma Stocks to Buy (Insider Monkey)
Jul-25-23 04:01PM	Ironwood Pharmaceuticals to Host Second Quarter 2023 Investor Update Call (Business Wire)
08:30AM	Loading…
Jun-29-23 08:30AM	Ironwood and VectivBio Announce the Completion of the Tender Offer for VectivBio Shares (Business Wire)
Jun-21-23 08:00PM	IRWD: Lowering target price to $11.00 (Argus Research)
Jun-16-23 07:00AM	Ironwood and VectivBio Announce Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition of VectivBio (Business Wire)
Jun-13-23 09:18AM	Ironwood (IRWD), AbbVie Get FDA Nod for Linzess Label Expansion (Zacks)
Jun-12-23 04:05PM	Ironwood Pharmaceuticals Announces FDA Approval of New Indication for LINZESS® (linaclotide) for the Treatment of Functional Constipation in Pediatric Patients Ages 6-17 Years-Old (Business Wire)
09:54AM	Down 7% in 2023, This Struggling Growth Stock Could Soon Make a Turnaround (Motley Fool)
May-25-23 10:32AM	Biotech Stock Roundup: IRWD Announces Buyout, ICPT, SRPT & PTCT Fall on Updates (Zacks)
May-23-23 12:07PM	Ironwood (IRWD) to Acquire VectivBio for $1B, Stock Up 3.6% (Zacks)
May-22-23 05:43PM	Why Ironwood Pharmaceuticals Stock Bumped Higher Today (Motley Fool)
04:08PM	VectivBio Stock Catapults 39% After Ironwood Agrees To Buy It For $1 Billion (Investor's Business Daily)
01:11PM	Ironwood spends $1B to acquire Swiss biotech (American City Business Journals)
12:02PM	Why Shares of VectivBio Holding Are Up Today (Motley Fool)
08:40AM	Ironwood Pharmaceuticals to Buy VectivBio in $1 Billion Deal. The Sector Is Hot for M&A. (Barrons.com)
07:24AM	UPDATE 1-Ironwood Pharma to acquire VectivBio for $1.15 bln (Reuters)
07:22AM	Ironwood bulks up on digestive therapies with $1.15 billion VectivBio buy (Reuters)
06:57AM	Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases (Business Wire)
May-09-23 04:01PM	Ironwood Pharmaceuticals to Participate in The JMP Securities Life Sciences Conference (Business Wire)
May-08-23 07:30AM	Ironwood Presents New Data on Potential of Linaclotide for Functional Constipation in Children and Adolescents Ages 6-17 Years-Old at Digestive Disease Week® 2023 (Business Wire)
May-05-23 09:31AM	Ironwood (IRWD) Q1 Earnings Beat Estimates, Linzess Volume Up (Zacks)
May-04-23 08:55AM	Ironwood Pharmaceuticals (IRWD) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
07:00AM	Ironwood Pharmaceuticals Reports First Quarter 2023 Results; Maintains Full Year 2023 Financial Guidance (Business Wire)
Apr-26-23 08:00PM	IRWD: What does Argus have to say about IRWD? (Argus Research)
Apr-24-23 07:30AM	Ironwood to Present New Data at Digestive Disease Week® 2023 Demonstrating Potential of Linaclotide for Functional Constipation in Children and Adolescents Ages 6-17 Years-Old (Business Wire)
Apr-20-23 04:01PM	Ironwood Pharmaceuticals to Host First Quarter 2023 Investor Update Call (Business Wire)
Mar-22-23 02:53PM	Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? (Simply Wall St.)
Mar-14-23 02:56AM	Strength Seen in Xencor (XNCR): Can Its 5.3% Jump Turn into More Strength? (Zacks)
Mar-02-23 07:09AM	Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Could Be 40% Below Their Intrinsic Value Estimate (Simply Wall St.)
Feb-27-23 04:01PM	Ironwood Pharmaceuticals to Participate in Upcoming Investor Conferences (Business Wire)
Feb-20-23 07:40AM	Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2022 Earnings Call Transcript (Insider Monkey)
Feb-17-23 11:11AM	Ironwood (IRWD) Q4 Earnings Miss, Linzess Volume Increases (Zacks)
Feb-16-23 08:35AM	Ironwood Pharmaceuticals (IRWD) Misses Q4 Earnings and Revenue Estimates (Zacks)
07:00AM	Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Results (Business Wire)
Feb-15-23 11:09AM	Drug/Biotech Stocks Q4 Earnings Due on Feb 16: ALKS, RARE & Others (Zacks)
Feb-14-23 10:00AM	BioCryst Pharmaceuticals (BCRX) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
07:20AM	Ironwood (IRWD) Gets FDA Priority Tag for Linzess sNDA (Zacks)
Feb-13-23 07:30AM	Ironwood Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of Supplemental New Drug Application for LINZESS® (linaclotide) for Functional Constipation in Children and Adolescents Ages 6-17 Years-Old (Business Wire)
Feb-10-23 07:40AM	15 Small Innovative Companies According to the Media (Insider Monkey)
Feb-09-23 10:01AM	Ironwood Pharmaceuticals (IRWD) Earnings Expected to Grow: Should You Buy? (Zacks)
Feb-04-23 09:40AM	3 No-Brainer Stocks to Buy Right Now for Less Than $25 (Motley Fool)
Feb-02-23 04:01PM	Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2022 Investor Update Call (Business Wire)
Jan-23-23 11:07AM	12 Most Undervalued Pharma Stocks To Buy According To Hedge Funds (Insider Monkey)
Jan-16-23 05:36AM	Ironwood Pharmaceuticals (NASDAQ:IRWD) shareholders are up 3.7% this past week, but still in the red over the last five years (Simply Wall St.)
Jan-09-23 06:00AM	Ironwood Pharmaceuticals Provides Update on FY 2022 Financial Guidance and Announces FY 2023 Financial Guidance (Business Wire) -10.99%
Jan-04-23 04:01PM	Ironwood Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference (Business Wire)
Dec-09-22 11:30AM	Catalyst (CPRX) Up 8.9% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-22-22 04:01PM	Ironwood Pharmaceuticals to Participate in the Piper Sandler 34th Annual Healthcare Conference (Business Wire)
Nov-09-22 07:47AM	Ironwood Pharmaceuticals Third Quarter 2022 Earnings: Misses Expectations (Simply Wall St.)
Nov-04-22 12:13PM	Ironwood's (IRWD) Q3 Earnings Beat, Linzess Volume Grows (Zacks)
Nov-03-22 08:35AM	Ironwood Pharmaceuticals (IRWD) Beats Q3 Earnings Estimates (Zacks)
07:01AM	Ironwood Pharmaceuticals Reports Strong Third Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance (Business Wire)
Oct-20-22 04:01PM	Ironwood Pharmaceuticals to Host Third Quarter 2022 Investor Update Call (Business Wire)
01:43PM	2 Health Care Stocks That Fit Graham's Lost Formula (GuruFocus.com)
Sep-25-22 09:48AM	Will Weakness in Ironwood Pharmaceuticals, Inc.'s (NASDAQ:IRWD) Stock Prove Temporary Given Strong Fundamentals? (Simply Wall St.)
Sep-07-22 10:02AM	Ironwood's (IRWD) Functional Constipation Study in Kids Succeeds (Zacks)
Sep-06-22 09:26AM	Ironwood's Constipation Drug Shows Efficacy In Pediatric Patients (Benzinga)
07:00AM	Ironwood Pharmaceuticals Reports Positive Topline Data from Phase III Trial of LINZESS® (linaclotide) in Pediatric Patients Aged 6-17 with Functional Constipation (Business Wire)
Sep-01-22 04:01PM	Ironwood Pharmaceuticals to Present at the 2022 Wells Fargo Healthcare Conference (Business Wire)
Aug-29-22 08:22AM	These 4 Measures Indicate That Ironwood Pharmaceuticals (NASDAQ:IRWD) Is Using Debt Safely (Simply Wall St.)
Aug-08-22 01:25PM	The 3.7% return this week takes Ironwood Pharmaceuticals' (NASDAQ:IRWD) shareholders three-year gains to 25% (Simply Wall St.)
Aug-05-22 11:45AM	Ironwood (IRWD) Q2 Earnings Miss, Keeps 2022 Sales Guidance (Zacks)
Aug-04-22 08:45AM	Ironwood Pharmaceuticals (IRWD) Misses Q2 Earnings and Revenue Estimates (Zacks)
07:00AM	Ironwood Pharmaceuticals Reports Second Quarter 2022 Results; Maintains Full Year Guidance Due to Continued Strength of LINZESS® Prescription Demand (Business Wire)
Jul-21-22 04:01PM	Ironwood Pharmaceuticals to Host Second Quarter 2022 Investor Update Call (Business Wire)
Jun-03-22 07:21PM	Keurig Dr Pepper, VICI Properties and ON Semiconductor Set to Join S&P 500; Others to Join S&P MidCap 400, and S&P SmallCap 600 (PR Newswire)
May-25-22 07:30AM	Ironwood Presents New Data Demonstrating Potential of IW-3300 for Visceral Pain at Digestive Disease Week® (DDW) 2022 (Business Wire)
May-09-22 08:00AM	Ironwood Pharmaceuticals to Present New IW-3300 and Linaclotide Data at Digestive Disease Week® 2022 (Business Wire)
May-06-22 10:24AM	Ironwood (IRWD) Q1 Earnings Miss, Linzess Growth Continues (Zacks)
May-05-22 08:45AM	Ironwood Pharmaceuticals (IRWD) Q1 Earnings Miss Estimates (Zacks)
07:00AM	Ironwood Pharmaceuticals Reports First Quarter 2022 Results; Maintains Full Year 2022 Financial Guidance (Business Wire)
Apr-28-22 03:02PM	Ironwood Pharmaceuticals (IRWD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)

Ironwood Pharmaceuticals, Inc. is a healthcare company, which engages in the development and commercialization of Gastrointestinal (GI) products. It operates through the Human Therapeutics segment. The company was founded on January 5, 1998 and is headquartered in Boston, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Davis Andrew	SVP, Chief Business Officer	Nov 20	Sale	9.69	3,287	31,851	217,374	Nov 22 04:05 PM
Emany Sravan Kumar	SVP, Chief Financial Officer	Sep 15	Buy	8.32	36,072	300,119	188,730	Sep 18 05:07 PM
John Minardo	Chief Legal Officer	Aug 14	Sale	10.04	7,045	70,732	192,195	Aug 16 04:20 PM
Silver Ronald	Principal Accounting Officer	Aug 14	Sale	10.04	1,976	19,839	134,172	Aug 16 04:21 PM
MCCOURT Thomas A	Chief Executive Officer	May 30	Sale	10.70	26,632	284,962	758,284	Jun 01 05:45 PM
MCCOURT Thomas A	Chief Executive Officer	May 22	Sale	10.12	36,000	364,320	784,916	May 24 04:05 PM
Shetzline Michael	CMO,SVP,Head-Res&Drug	May 22	Sale	10.12	10,324	104,479	321,131	May 24 04:05 PM
Davis Andrew	SVP, Chief Business Officer	May 22	Sale	10.12	6,305	63,807	219,327	May 24 04:05 PM
MCCOURT Thomas A	Chief Executive Officer	May 08	Sale	10.62	21,148	224,592	820,916	May 10 04:05 PM
MCCOURT Thomas A	Chief Executive Officer	Mar 27	Sale	10.67	46,129	492,196	842,064	Mar 29 04:05 PM
MCCOURT Thomas A	Chief Executive Officer	Mar 03	Sale	11.22	33,756	378,742	647,598	Mar 07 04:05 PM
MCCOURT Thomas A	Chief Executive Officer	Feb 28	Sale	11.31	31,227	353,177	681,354	Mar 01 06:22 PM
Rickard Jason	SVP, Chief Operating Officer	Feb 28	Sale	11.31	17,429	197,122	332,648	Mar 01 06:24 PM
Shetzline Michael	CMO,SVP,Head-Res&Drug	Feb 28	Sale	11.31	9,854	111,449	261,586	Mar 01 06:21 PM
John Minardo	Chief Legal Officer	Feb 28	Sale	11.31	3,415	38,624	133,738	Mar 01 06:19 PM
Silver Ronald	Principal Accounting Officer	Feb 28	Sale	11.31	3,049	34,484	98,491	Mar 01 06:25 PM
Davis Andrew	SVP, Chief Business Officer	Feb 28	Sale	11.31	1,822	20,607	151,396	Mar 01 06:17 PM
MCCOURT Thomas A	Chief Executive Officer	Feb 27	Sale	11.41	30,004	342,346	712,581	Mar 01 06:22 PM
Rickard Jason	SVP, Chief Operating Officer	Feb 27	Sale	11.41	16,746	191,072	350,077	Mar 01 06:24 PM
Shetzline Michael	CMO,SVP,Head-Res&Drug	Feb 27	Sale	11.41	9,468	108,030	271,440	Mar 01 06:21 PM
John Minardo	Chief Legal Officer	Feb 27	Sale	11.41	3,282	37,448	137,153	Mar 01 06:19 PM
Silver Ronald	Principal Accounting Officer	Feb 27	Sale	11.41	2,929	33,420	101,540	Mar 01 06:25 PM
Davis Andrew	SVP, Chief Business Officer	Feb 27	Sale	11.41	1,751	19,979	153,218	Mar 01 06:17 PM
MCCOURT Thomas A	Chief Executive Officer	Jan 05	Option Exercise	11.65	110,962	1,292,707	823,402	Jan 09 04:05 PM
MCCOURT Thomas A	Chief Executive Officer	Jan 05	Sale	12.07	110,962	1,339,311	712,440	Jan 09 04:05 PM
Rickard Jason	SVP, Chief Operating Officer	Dec 14	Sale	12.39	27,000	334,530	348,736	Dec 16 04:05 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IRWD

Ironwood Pharmaceuticals Inc

Upgrade your FINVIZ experience